<h1>Patient MM082 â€“ Pathway Analysis Report</h1>
<h2>Predicted Class: no_effect</h2>
<p><strong>LLM Summary:</strong><br></p>
<h3>Positive SHAP Features Enrichment</h3>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>Gene_set</th>
      <th>Term</th>
      <th>Overlap</th>
      <th>P-value</th>
      <th>Adjusted P-value</th>
      <th>Old P-value</th>
      <th>Old Adjusted P-value</th>
      <th>Odds Ratio</th>
      <th>Combined Score</th>
      <th>Genes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>regulation of cell-cell adhesion mediated by integrin (GO:0033632)</td>
      <td>2/10</td>
      <td>0.000091</td>
      <td>0.030836</td>
      <td>0</td>
      <td>0</td>
      <td>184.842593</td>
      <td>1720.515946</td>
      <td>CD3E;ADA</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>substantia nigra development (GO:0021762)</td>
      <td>2/43</td>
      <td>0.001767</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>36.007227</td>
      <td>228.234922</td>
      <td>GLUD1;CNP</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>posttranscriptional regulation of gene expression (GO:0010608)</td>
      <td>2/46</td>
      <td>0.002020</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>33.547138</td>
      <td>208.154774</td>
      <td>NUDT21;RBM4B</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>regulation of immune response (GO:0050776)</td>
      <td>3/179</td>
      <td>0.002171</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>12.977491</td>
      <td>79.587669</td>
      <td>IL15;ICAM3;CD3E</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of T cell proliferation (GO:0042102)</td>
      <td>2/66</td>
      <td>0.004111</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>23.040509</td>
      <td>126.585458</td>
      <td>IL15;CD3E</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of T cell activation (GO:0050870)</td>
      <td>2/75</td>
      <td>0.005276</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>20.190766</td>
      <td>105.892270</td>
      <td>IL15;CD3E</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of lymphocyte proliferation (GO:0050671)</td>
      <td>2/75</td>
      <td>0.005276</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>20.190766</td>
      <td>105.892270</td>
      <td>IL15;CD3E</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>regulation of T cell proliferation (GO:0042129)</td>
      <td>2/76</td>
      <td>0.005414</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>19.916917</td>
      <td>103.942726</td>
      <td>IL15;CD3E</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>protein-containing complex assembly (GO:0065003)</td>
      <td>3/267</td>
      <td>0.006651</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>8.613199</td>
      <td>43.177249</td>
      <td>CUL1;SNX9;CD3E</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>cellular response to indole-3-methanol (GO:0071681)</td>
      <td>1/5</td>
      <td>0.007230</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>178.276786</td>
      <td>878.827148</td>
      <td>CTNNA1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>glutamate catabolic process (GO:0006538)</td>
      <td>1/5</td>
      <td>0.007230</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>178.276786</td>
      <td>878.827148</td>
      <td>GLUD1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>oocyte development (GO:0048599)</td>
      <td>1/5</td>
      <td>0.007230</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>178.276786</td>
      <td>878.827148</td>
      <td>YTHDC2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>response to indole-3-methanol (GO:0071680)</td>
      <td>1/5</td>
      <td>0.007230</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>178.276786</td>
      <td>878.827148</td>
      <td>CTNNA1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive thymic T cell selection (GO:0045059)</td>
      <td>1/5</td>
      <td>0.007230</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>178.276786</td>
      <td>878.827148</td>
      <td>CD3E</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>inosine metabolic process (GO:0046102)</td>
      <td>1/5</td>
      <td>0.007230</td>
      <td>0.109939</td>
      <td>0</td>
      <td>0</td>
      <td>178.276786</td>
      <td>878.827148</td>
      <td>ADA</td>
    </tr>
  </tbody>
</table>
<h3>Negative SHAP Features Enrichment</h3>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>Gene_set</th>
      <th>Term</th>
      <th>Overlap</th>
      <th>P-value</th>
      <th>Adjusted P-value</th>
      <th>Old P-value</th>
      <th>Old Adjusted P-value</th>
      <th>Odds Ratio</th>
      <th>Combined Score</th>
      <th>Genes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>neutrophil degranulation (GO:0043312)</td>
      <td>5/481</td>
      <td>0.000683</td>
      <td>0.048739</td>
      <td>0</td>
      <td>0</td>
      <td>8.190756</td>
      <td>59.701767</td>
      <td>CTSZ;HLA-B;HP;SRP14;SERPINB6</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of T cell mediated cytotoxicity (GO:0001916)</td>
      <td>2/26</td>
      <td>0.000691</td>
      <td>0.048739</td>
      <td>0</td>
      <td>0</td>
      <td>59.363095</td>
      <td>431.986709</td>
      <td>HLA-B;HLA-DRA</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>neutrophil activation involved in immune response (GO:0002283)</td>
      <td>5/485</td>
      <td>0.000709</td>
      <td>0.048739</td>
      <td>0</td>
      <td>0</td>
      <td>8.120833</td>
      <td>58.888468</td>
      <td>CTSZ;HLA-B;HP;SRP14;SERPINB6</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>neutrophil mediated immunity (GO:0002446)</td>
      <td>5/488</td>
      <td>0.000729</td>
      <td>0.048739</td>
      <td>0</td>
      <td>0</td>
      <td>8.069151</td>
      <td>58.289235</td>
      <td>CTSZ;HLA-B;HP;SRP14;SERPINB6</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>regulation of T cell mediated cytotoxicity (GO:0001914)</td>
      <td>2/29</td>
      <td>0.000861</td>
      <td>0.048739</td>
      <td>0</td>
      <td>0</td>
      <td>52.759259</td>
      <td>372.337458</td>
      <td>HLA-B;HLA-DRA</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of T cell mediated immunity (GO:0002711)</td>
      <td>2/36</td>
      <td>0.001328</td>
      <td>0.062615</td>
      <td>0</td>
      <td>0</td>
      <td>41.882353</td>
      <td>277.447268</td>
      <td>HLA-B;HLA-DRA</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of leukocyte mediated cytotoxicity (GO:0001912)</td>
      <td>2/43</td>
      <td>0.001890</td>
      <td>0.076427</td>
      <td>0</td>
      <td>0</td>
      <td>34.719512</td>
      <td>217.724534</td>
      <td>HLA-B;HLA-DRA</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>interferon-gamma-mediated signaling pathway (GO:0060333)</td>
      <td>2/68</td>
      <td>0.004659</td>
      <td>0.087869</td>
      <td>0</td>
      <td>0</td>
      <td>21.541126</td>
      <td>115.651453</td>
      <td>HLA-B;HLA-DRA</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>regulation of actin filament-based process (GO:0032970)</td>
      <td>2/73</td>
      <td>0.005350</td>
      <td>0.087869</td>
      <td>0</td>
      <td>0</td>
      <td>20.019115</td>
      <td>104.711691</td>
      <td>ARHGAP18;RHOC</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>regulation of neuron death (GO:1901214)</td>
      <td>2/86</td>
      <td>0.007352</td>
      <td>0.087869</td>
      <td>0</td>
      <td>0</td>
      <td>16.909864</td>
      <td>83.074368</td>
      <td>GPNMB;CTSZ</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261)</td>
      <td>1/5</td>
      <td>0.007478</td>
      <td>0.087869</td>
      <td>0</td>
      <td>0</td>
      <td>172.120690</td>
      <td>842.662296</td>
      <td>DAG1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)</td>
      <td>1/5</td>
      <td>0.007478</td>
      <td>0.087869</td>
      <td>0</td>
      <td>0</td>
      <td>172.120690</td>
      <td>842.662296</td>
      <td>HLA-DRA</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259)</td>
      <td>1/5</td>
      <td>0.007478</td>
      <td>0.087869</td>
      <td>0</td>
      <td>0</td>
      <td>172.120690</td>
      <td>842.662296</td>
      <td>DAG1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>negative regulation of hydrogen peroxide metabolic process (GO:0010727)</td>
      <td>1/5</td>
      <td>0.007478</td>
      <td>0.087869</td>
      <td>0</td>
      <td>0</td>
      <td>172.120690</td>
      <td>842.662296</td>
      <td>HP</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>disaccharide biosynthetic process (GO:0046351)</td>
      <td>1/5</td>
      <td>0.007478</td>
      <td>0.087869</td>
      <td>0</td>
      <td>0</td>
      <td>172.120690</td>
      <td>842.662296</td>
      <td>FBP2</td>
    </tr>
  </tbody>
</table>
<h2>Predicted Class: positive_effect</h2>
<p><strong>LLM Summary:</strong><br>The SHAP features indicate a "positive_effect" is supported by pathways primarily involved in **negative regulation of gene expression, particularly through microRNA (miRNA) mediated silencing**. Key genes in this process include AGO1, EIF4E2, and YY1, which are involved in mRNA cleavage, miRNA loading onto RISC, and regulation of translation. Other supporting pathways include lipoxin metabolic processes (ALOX5AP), mitochondrion localization (RHOT2), and death-inducing signaling complex assembly (TRADD).

Conversely, pathways that argue against the "positive_effect" are largely centered around **pyrimidine metabolism** (DHODH), **vascular endothelial growth factor (VEGF) signaling** (MYO1C), and **antigen processing and presentation/peptide transport** (TAP2). Additionally, the regulation of chemokine-mediated signaling pathways (RNF113A) also appears to oppose the "positive_effect".</p>
<h3>Positive SHAP Features Enrichment</h3>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>Gene_set</th>
      <th>Term</th>
      <th>Overlap</th>
      <th>P-value</th>
      <th>Adjusted P-value</th>
      <th>Old P-value</th>
      <th>Old Adjusted P-value</th>
      <th>Odds Ratio</th>
      <th>Combined Score</th>
      <th>Genes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>negative regulation of gene expression (GO:0010629)</td>
      <td>3/322</td>
      <td>0.000456</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>26.427676</td>
      <td>203.297422</td>
      <td>YY1;AGO1;EIF4E2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>mRNA cleavage involved in gene silencing by miRNA (GO:0035279)</td>
      <td>1/5</td>
      <td>0.002498</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>555.166667</td>
      <td>3326.770642</td>
      <td>AGO1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>establishment of mitochondrion localization, microtubule-mediated (GO:0034643)</td>
      <td>1/6</td>
      <td>0.002997</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>444.111111</td>
      <td>2580.411794</td>
      <td>RHOT2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>lipoxin metabolic process (GO:2001300)</td>
      <td>1/6</td>
      <td>0.002997</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>444.111111</td>
      <td>2580.411794</td>
      <td>ALOX5AP</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>death-inducing signaling complex assembly (GO:0071550)</td>
      <td>1/7</td>
      <td>0.003495</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>370.074074</td>
      <td>2093.271349</td>
      <td>TRADD</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>regulation of miRNA mediated inhibition of translation (GO:1905616)</td>
      <td>1/7</td>
      <td>0.003495</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>370.074074</td>
      <td>2093.271349</td>
      <td>EIF4E2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280)</td>
      <td>1/7</td>
      <td>0.003495</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>370.074074</td>
      <td>2093.271349</td>
      <td>AGO1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>lipoxin biosynthetic process (GO:2001301)</td>
      <td>1/7</td>
      <td>0.003495</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>370.074074</td>
      <td>2093.271349</td>
      <td>ALOX5AP</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of miRNA mediated inhibition of translation (GO:1905618)</td>
      <td>1/7</td>
      <td>0.003495</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>370.074074</td>
      <td>2093.271349</td>
      <td>EIF4E2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>RNA secondary structure unwinding (GO:0010501)</td>
      <td>1/8</td>
      <td>0.003994</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>317.190476</td>
      <td>1751.859055</td>
      <td>AGO1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>negative regulation of macromolecule metabolic process (GO:0010605)</td>
      <td>2/194</td>
      <td>0.004002</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>25.778646</td>
      <td>142.322883</td>
      <td>YY1;AGO1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>small RNA loading onto RISC (GO:0070922)</td>
      <td>1/9</td>
      <td>0.004492</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>277.527778</td>
      <td>1500.174168</td>
      <td>AGO1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>response to UV-C (GO:0010225)</td>
      <td>1/9</td>
      <td>0.004492</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>277.527778</td>
      <td>1500.174168</td>
      <td>YY1</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)</td>
      <td>1/9</td>
      <td>0.004492</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>277.527778</td>
      <td>1500.174168</td>
      <td>RHOT2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>negative regulation of interferon-beta production (GO:0032688)</td>
      <td>1/10</td>
      <td>0.004990</td>
      <td>0.04112</td>
      <td>0</td>
      <td>0</td>
      <td>246.679012</td>
      <td>1307.486550</td>
      <td>YY1</td>
    </tr>
  </tbody>
</table>
<h3>Negative SHAP Features Enrichment</h3>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>Gene_set</th>
      <th>Term</th>
      <th>Overlap</th>
      <th>P-value</th>
      <th>Adjusted P-value</th>
      <th>Old P-value</th>
      <th>Old Adjusted P-value</th>
      <th>Odds Ratio</th>
      <th>Combined Score</th>
      <th>Genes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>pyrimidine nucleobase biosynthetic process (GO:0019856)</td>
      <td>1/5</td>
      <td>0.002498</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>555.166667</td>
      <td>3326.770642</td>
      <td>DHODH</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>pyrimidine ribonucleotide metabolic process (GO:0009218)</td>
      <td>1/5</td>
      <td>0.002498</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>555.166667</td>
      <td>3326.770642</td>
      <td>DHODH</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)</td>
      <td>1/6</td>
      <td>0.002997</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>444.111111</td>
      <td>2580.411794</td>
      <td>MYO1C</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668)</td>
      <td>1/6</td>
      <td>0.002997</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>444.111111</td>
      <td>2580.411794</td>
      <td>TAP2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>negative regulation of chemokine-mediated signaling pathway (GO:0070100)</td>
      <td>1/6</td>
      <td>0.002997</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>444.111111</td>
      <td>2580.411794</td>
      <td>RNF113A</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>peptide transport (GO:0015833)</td>
      <td>1/7</td>
      <td>0.003495</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>370.074074</td>
      <td>2093.271349</td>
      <td>TAP2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>pyrimidine ribonucleotide biosynthetic process (GO:0009220)</td>
      <td>1/7</td>
      <td>0.003495</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>370.074074</td>
      <td>2093.271349</td>
      <td>DHODH</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>pyrimidine-containing compound biosynthetic process (GO:0072528)</td>
      <td>1/7</td>
      <td>0.003495</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>370.074074</td>
      <td>2093.271349</td>
      <td>DHODH</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885)</td>
      <td>1/8</td>
      <td>0.003994</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>317.190476</td>
      <td>1751.859055</td>
      <td>TAP2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>regulation of chemokine-mediated signaling pathway (GO:0070099)</td>
      <td>1/8</td>
      <td>0.003994</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>317.190476</td>
      <td>1751.859055</td>
      <td>RNF113A</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089)</td>
      <td>1/8</td>
      <td>0.003994</td>
      <td>0.032312</td>
      <td>0</td>
      <td>0</td>
      <td>317.190476</td>
      <td>1751.859055</td>
      <td>MYO1C</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)</td>
      <td>2/251</td>
      <td>0.006606</td>
      <td>0.033683</td>
      <td>0</td>
      <td>0</td>
      <td>19.820281</td>
      <td>99.494008</td>
      <td>RNF113A;U2AF2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>antigen processing and presentation of endogenous peptide antigen (GO:0002483)</td>
      <td>1/14</td>
      <td>0.006979</td>
      <td>0.033683</td>
      <td>0</td>
      <td>0</td>
      <td>170.743590</td>
      <td>847.704662</td>
      <td>TAP2</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>vascular endothelial growth factor signaling pathway (GO:0038084)</td>
      <td>1/14</td>
      <td>0.006979</td>
      <td>0.033683</td>
      <td>0</td>
      <td>0</td>
      <td>170.743590</td>
      <td>847.704662</td>
      <td>MYO1C</td>
    </tr>
    <tr>
      <td>GO_Biological_Process_2021</td>
      <td>positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774)</td>
      <td>1/14</td>
      <td>0.006979</td>
      <td>0.033683</td>
      <td>0</td>
      <td>0</td>
      <td>170.743590</td>
      <td>847.704662</td>
      <td>C2CD2L</td>
    </tr>
  </tbody>
</table>